MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/hep.0000000000000653

Медицинская библиотека · Hepatology (Baltimore, Md.) · 2023

Determinants of clinical response to empirical antibiotic treatment in patients with cirrhosis and bacterial and fungal infections-Results from the ICA "Global Study" (EABCIR-Global Study).

Maiwall Rakhi, Piano Salvatore, Singh Virendra, Caraceni Paolo, Alessandria Carlo, Fernandez Javier, Soares Elza Cotrim, Kim Dong Joon, Kim Sung Eun, Marino Monica, Vorobioff Julio, Ribeiro Barea Rita de Cassia, Merli Manuela, Elkrief Laure, Vargas Victor, Krag Aleksander, Singh Shivaram Prasad, Lesmana Laurentius Adrianto, Toledo Claudio, Marciano Sebastian, Verhelst Xavier, Wong Florence, Intagliata Nicolas, Rabinowich Liane, Colombato Luis, Kim Sang Gyune, Gerbes Alexander, Durand Francois, Roblero Juan Pablo, Bhamidimarri Kalyan Ram, Maevskaya Marina, Fassio Eduardo, Kim Hyoung Su, Hwang Jae Seok, Gines Pere, Bruns Tony, Gadano Adrian, Angeli Paolo, Sarin Shiv Kumar, International Club of Ascites Global Study Group

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

The administration of an appropriate empirical antibiotic treatment is essential in cirrhosis and severe bacterial infections. We aimed to investigate the predictors of clinical response of empirical antibiotic treatment in a prospective cohort of patients with cirrhosis and bacterial and fungal infections included in the International Club of Ascites "Global Study."

METHODS

Patients hospitalized with cirrhosis and bacterial/fungal infection were prospectively enrolled at 46 centers. Clinical response to antibiotic treatment was defined according to changes in markers of infection/inflammation, vital signs, improvement of organ failure, and results of cultures.

RESULTS

From October 2015 to September 2016, 1302 patients were included at 46 centers. A clinical response was achieved in only 61% of cases. Independent predictors of lack of clinical response to empirical treatment were C-reactive protein (OR = 1.16; 95% CI = 1.02-1.31), blood leukocyte count (OR = 1.39;95% CI = 1.09-1.77), serum albumin (OR = 0.70; 95% CI = 0.55-0.88), nosocomial infections (OR = 1.96; 95% CI = 1.20-2.38), pneumonia (OR = 1.75; 95% CI = 1.22-2.53), and ineffective treatment according to antibiotic susceptibility test (OR = 5.32; 95% CI = 3.47-8.57). Patients with a lack of clinical response to first-line antibiotic treatment had a significantly lower resolution rate of infections (55% vs. 96%; p < 0.001), a higher incidence of second infections (29% vs. 15%; p < 0.001), shock (35% vs. 7%; p < 0.001) and new organ failures (52% vs. 19 %; p < 0.001) than responders. Clinical response to empirical treatment was an independent predictor of 28-day survival ( subdistribution = 0.20; 95% CI = 0.14-0.27).

CONCLUSIONS

Four out of 10 patients with cirrhosis do not respond to the first-line antibiotic therapy, leading to lower resolution of infections and higher mortality. Broader-spectrum antibiotics and strategies targeting systemic inflammation may improve prognosis in patients with a high degree of inflammation, low serum albumin levels, and severe liver impairment.

Для цитирования: Maiwall Rakhi, Piano Salvatore, Singh Virendra, Caraceni Paolo, Alessandria Carlo, Fernandez Javier, Soares Elza Cotrim, Kim Dong Joon, Kim Sung Eun, Marino Monica, Vorobioff Julio, Ribeiro Barea Rita de Cassia, Merli Manuela, Elkrief Laure, Vargas Victor, Krag Aleksander, Singh Shivaram Prasad, Lesmana Laurentius Adrianto, Toledo Claudio, Marciano Sebastian, Verhelst Xavier, Wong Florence, Intagliata Nicolas, Rabinowich Liane, Colombato Luis, Kim Sang Gyune, Gerbes Alexander, Durand Francois, Roblero Juan Pablo, Bhamidimarri Kalyan Ram, Maevskaya Marina, Fassio Eduardo, Kim Hyoung Su, Hwang Jae Seok, Gines Pere, Bruns Tony, Gadano Adrian, Angeli Paolo, Sarin Shiv Kumar, International Club of Ascites Global Study Group. Determinants of clinical response to empirical antibiotic treatment in patients with cirrhosis and bacterial and fungal infections-Results from the ICA "Global Study" (EABCIR-Global Study).. Hepatology (Baltimore, Md.). 2023. DOI: 10.1097/hep.0000000000000653.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.